Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Interleukin-6
(
IL-6
) is a neuropoietic cytokine which is dramatically upregulated following peripheral nerve injury at the site of injury, in the dorsal root ganglion (DRG) and in the spinal cord. The functional effects of
IL-6
in nociception in normal conditions and following nerve injury are unclear. Thus the aim of this study was to assess the effect of spinal
IL-6
administration on nociceptive transmission in naive, sham-operated and neuropathic (spinal nerve ligation,
SNL
) rats using in vivo electrophysiology to elucidate the possible role of
IL-6
in neuropathic pain. In anaesthetised rats, extracellular recordings were made from individual convergent dorsal horn neurones following electrical and natural (mechanical and thermal) stimulation of peripheral receptive fields. Exogenous spinal
IL-6
(100-500 ng) had no significant effect on electrically evoked neuronal responses in naive rats. In contrast, following neuropathy, spinal
IL-6
produced a dose-related inhibition of the electrically evoked C-fibre, initial C-fibre and measures of neuronal hyperexcitability (post discharge and wind-up). In addition, spinal
IL-6
markedly inhibited mechanical neuronal responses in neuropathic rats. Higher doses of spinal
IL-6
also inhibited, to a lesser degree, the initial C-fibre, post discharge and wind-up responses in sham-operated rats. These studies show that following nerve injury the actions of the cytokine alter so that spinal administration of
IL-6
elicits anti-nociceptive effects not observed under normal conditions. Moreover, the inhibitory effects of
IL-6
on C-fibre activity and neuronal hyperexcitability, suggest
IL-6
to be a potential modulator of neuropathic pain.
...
PMID:Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. 1293 39